CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company
BIOMERICA INC
Sign in to watch- Ticker
- BMRA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 952645573
- Phone
- 9493792875
- Business address
- 17571 VON KARMAN AVENUE, IRVINE, CA, 92614
- 4/A Open-market buy Chief Executive Officer bought 2,000 shares at $0.85 ($1,700)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $1.08 ($3,240)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $0.85 ($1,700)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy Chief Executive Officer bought 18,000 shares at an average $0.91 ($16,390)
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 10-Q Report Quarterly Report
- 4 Option exercise President acquired 7,000 shares (option exercise)
- 4 Option exercise Secretary acquired 5,000 shares (option exercise)
Page 18 of 31 · 605 filings